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Systems biology solutions for biochemical production
challenges
Anne Sofie Lærke Hansen, Rebecca M Lennen,
Nikolaus Sonnenschein and Markus J Herrga˚rd
There is an urgent need to significantly accelerate the
development of microbial cell factories to produce fuels and
chemicals from renewable feedstocks in order to facilitate the
transition to a biobased society. Methods commonly used
within the field of systems biology including omics
characterization, genome-scale metabolic modeling, and
adaptive laboratory evolution can be readily deployed in
metabolic engineering projects. However, high performance
strains usually carry tens of genetic modifications and need to
operate in challenging environmental conditions. This
additional complexity compared to basic science research
requires pushing systems biology strategies to their limits and
often spurs innovative developments that benefit fields outside
metabolic engineering. Here we survey recent advanced
applications of systems biology methods in engineering
microbial production strains for biofuels and -chemicals.
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Introduction
One of the key challenges in the 21st century is to identify
technical solutions for the transition away from a petro-
chemical-based economy. The production of chemicals
and fuels from renewable feedstocks in a commercially
and ecologically sustainable fashion is a central compo-
nent of these solutions [1]. A handful of bio-based che-
micals and fuels have already been commercialized for
industrial scale production including 1,3-propanediol [2],
succinic acid [3], and 1,4-butanediol [4]. However,
despite microbial fermentation-based production offering
multiple advantages over current petrochemical pro-
cesses, its full implementation has been hampered by
difficulties in reaching cost-effective yields from low cost
feedstocks [5].
Metabolic engineering offers a systematic workflow for
rational cell factory development by overexpression of
pathway genes, elimination of byproducts, balancing of
cofactors and increasing precursor supply among other
approaches [6,7]. Recent advances in the field of synthetic
biology, such as the development of the CRISPR/Cas9
system [8,9], and other genome editing tools, have
increased the pace and ease with which microbial cell
factories can be built [10–12]. However, the number of
obvious gene targets for optimization is limited, and
genetic manipulations often lead to unintended effects
due to complex genotype–phenotype relationships [6].
Facilitated by the emergence of high-throughput tech-
nologies like next-generation sequencing and quantita-
tive proteomics, systems biology offers several methods
to unravel complexity of microbial metabolism and
physiology.
The scope of systems biology is to investigate biological
systems in a holistic manner to elucidate the mechanisms
underlying the cellular behavior in contrast to the classic
reductionist approaches where single elements of the
system are studied in detail. Similarly, metabolic engi-
neering requires, in addition to manipulation of single
enzymes and pathways, also engineering of the interac-
tions between the target pathway and endogenous metab-
olism [6]. In the field of systems biology, quantitative
workflows have been developed in recent years to study
responses of microorganisms to relatively simple environ-
mental and genetic changes [13,14], together with data-
and model-driven approaches for predicting phenotypes
[15,16]. These workflows can now be extended to engi-
neered cell factories to understand effects of complex
manipulations and to design more robust and efficient
production organisms.
Here we review some of the most recent applications of
systems biology tools for metabolic engineering of micro-
organisms for sustainable production of chemicals with
special focus on non-native biofuels and bulk chemicals.
We will focus on three particular technology platforms
that have demonstrated impact in metabolic engineering:
omics data collection and analysis, genome-scale models
(GEMs) of cellular processes, and adaptive laboratory
evolution (ALE). Indeed, the integration of omics and
computational techniques together with the recent
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possibility to screen, select and fine-tune cellular
responses [17,18] hold promise to speed up the systems
metabolic engineering approach. In this context, GEMs
offer a useful framework for interpretation of collected
data as well as formulation and assessment of potential
engineering strategies. The application of ALE for sys-
tems-level optimization of host robustness and biochem-
ical production, and the subsequent investigation of
causal mutations by omics and computational analysis,
allows for simultaneous strain improvement and identifi-
cation of potential targets for further engineering.
Trends in omics characterization for
metabolic engineering
The use of the four major omics technologies (transcrip-
tomics, proteomics, metabolomics, and fluxomics)
applied to characterize cell systems behavior has
increased rapidly in metabolic engineering-related pub-
lications since 2010 (Figure 1). This increase has been
brought about both by growth of the metabolic engineer-
ing and biofuel fields as well as improvements in omics
technologies. Among different omics methods, the devel-
opment of the quantitative RNA sequencing method has
made transcriptomics by far the most commonly used
methodology followed by proteomics and in particular
targeted pathway-oriented proteomics (Figure 1b). The
use of metabolomics and fluxomics (typically 13C-based)
is still relatively rare in metabolic engineering studies
most likely due to both incomplete coverage of metab-
olites/fluxes, and challenges and/or costs in experimental
implementation. The majority of the metabolic engineer-
ing studies using omics data focus on common biofuels
that are produced natively (e.g., ethanol, n-butanol or fatty
acids) or on platform strains without aim to produce a
particular product (Figure 1c). Studies using omics tech-
nologies characterizing strains making non-native fine or
bulk chemicals are surprisingly rare despite well-docu-
mented ability of omics methods to discover potential
bottlenecks in engineered strains [19].
Recent years have seen the emergence of multi-omic
characterization studies that often also incorporate a
modeling component to study either platform or pro-
duction strains. Examples of such studies targeting
production strains include identification of bottlenecks
in terpenoid production in Escherichia coli [20], 3-hydro-
xypropionic acid production in baker’s yeast [21], and
L-lysine production in Corynebacterium glutamicum [22].
For platform strains, such studies have included compar-
isons of multiple possible wild type host strains [23], in
depth characterization of less-well-studied production
hosts [24], and determination of effects of major flux
re-routing in central metabolism [25]. Multi-omic char-
acterization has also become one of the key tools
in identification of mechanisms of adaptation in ALE
studies targeting either general stress or product tolerance
[26,27]. In recent years, standard omics data types
are increasingly complemented by genome-wide
screening of knock-out or knock-down libraries using,
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Trends in the use of four major omics technologies in metabolic engineering and biofuel publications since 2000. The list of over 500 publications
was collected by comprehensive literature searches performed on scopus using terms in title, abstract and keywords followed by manual curation.
Genomics was excluded due to the high number of publications using this technology. (a) Overall distribution of publications by omics data type
used. (b) Publication trends as a function of time categorized by type of host organism (heterotrophic bacterial host, fungal host or prokaryotic or
eukaryotic photosynthetic host) and omics technology used. (c) Publication trends as a function of time categorized by the type of study (biofuel,
bulk chemical, fine chemical, platform strain) and omics technology used.
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CRISPR/Cas9-based [30] methods. These methods allow
identification of targets for further genetic manipulation
more directly than other types of omics methods.
Genome-scale models for cell factory design
and omics data interpretation
In the context of metabolic engineering, GEMs represent
an invaluable tool for estimating theoretical maximum
yields (Figure 2), enumerating heterologous production
pathways with high yields [31], and predicting physio-
logical changes in redox balance or energy metabolism
upon perturbation [32]. Furthermore, numerous meth-
ods for computing strain engineering strategies by over-
expression, down-regulation, and/or deletion of genes
have been developed [33]. Of particular interest in the
context of ALE experiments are gene deletions that
couple the production of a desired product to growth.
These so-called growth-coupled designs [34] can be
implemented experimentally using ALE, as the selection
for higher growth phenotypes drives the organism in the
desired corner of the growth-production phenotype space
(Figure 2). Multiple algorithms for the computation of
growth-coupled designs have been published [35–37],
and in particular the use of metabolic cut sets [38] has
been demonstrated to be scalable to larger numbers of
knock-outs and has been recently used effectively for the
engineering of E. coli for the production of itaconic acid
[39].
Ideally, suitable experimental data can be used to shrink
the feasible solution space of GEMs to obtain more
reliable predictions (Figure 2). Quantitative analysis of
omics data with GEMs, however, has proven to be diffi-
cult. While numerous methods have been published for
the integration of transcriptomics and proteomics data
with GEMs, a comprehensive benchmark of published
methods [40] has revealed that none of these methods
surpass methods that do not take omics data into account
[41] in the quantitative prediction of metabolic fluxes.
While this does not preclude the use of GEMs in more
qualitative types of omics-data analyses [20,23,42],
the lack of ability to accurately predict rates of by-product
formation makes the model-guided analysis of transcrip-
tomics and proteomics data in strain engineering projects
challenging. New modeling approaches that extend
GEMs beyond metabolism provide a platform for direct
integration of proteomics and transcriptomics data [43]
and can result in improved flux predictions. Furthermore,
integrating multi-omic data with both mechanistic and
machine learning models that encompass additional cel-
lular systems, for example, transcriptional regulatory net-
works, could be a further avenue [44].
Significant new modeling method development will be
needed to allow interpretation of metabolomics data in
the context of GEMs as these models do not use metabo-
lite concentrations as state variables. Recently, Zelezniak
et al. [45] proposed a network based framework for
reconciling transcriptome changes with metabolome
changes highlighting the importance of network context
and kinetics. Finally, fluxomics data, that is, the measure-
ment of intracellular fluxes with 13C labeling experiments
[46,47] in addition to uptake and secretion rates, likely
holds the largest potential in informing metabolic engi-
neering projects, as such data can be incorporated unam-
biguously as flux constraints into GEMs. The main chal-
lenge with fluxomics data is the small number of fluxes
that can be directly estimated requiring the use of meth-
ods such as sampling to estimate the remaining fluxes
with GEMs.
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Experimental data integration and growth-coupled design with GEMs. The production envelopes of the initial strain (theoretical: blue, constrained
with experimental data: green), and a knock-out mutant strain predicted with genome-scale metabolic modelling (orange). The black dot indicates
the maximum theoretical product yield, the green dot indicates the typical initial growth and product yield, whereas the movement of the yellow
dot indicates how the growth and product yield of the growth-coupled knock-out production mutant strain is improved by ALE.
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Traditional and emerging uses of adaptive
laboratory evolution for metabolic engineering
Sparsity of biological knowledge necessitates both the use
of omics technologies as a characterization tool, and ALE
to determine non-intuitive routes to improve strain
robustness and production metrics. In a typical ALE
experiment (Figure 3a), a laboratory selection pressure
is maintained (in either batch cultures or a chemostat) to
select for cells with better growth, which are typically
acquired through spontaneous mutations. Ultimately,
individual isolates or populations with improved growth
under the selection condition are whole genome re-
sequenced to determine the acquired mutations. Evolved
isolates can then be used directly as production strains, or
selected mutations can be reintroduced into production
hosts to generate the desired phenotype.
Because of the requirement of a growth selection, more
traditional ALE studies (Figure 3b) relevant for biofuel
and chemical production applications have focused on
wild-type strains challenged with more direct effectors of
growth. ALE of E. coli on minimal glucose [48] and
minimal glycerol media [49] has resulted in the identifi-
cation of numerous key regulatory and metabolic muta-
tions. Two of these regulatory mutations in RNA poly-
merase were further studied by structural modeling,
transcriptomic, and metabolomic analyses to determine
a novel trade-off mechanism for growth in constant versus
fluctuating environments [50]. Both E. coli and Saccharo-
myces cerevisiae have been evolved for thermotolerance
[26,51,52] and osmotolerance [53,54], which are benefi-
cial traits for economical production of biofuels and bulk
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Adaptive laboratory evolution (ALE). (a) A typical ALE experiment consists of maintaining a selective pressure through either serial passaging of
batch cultures or using a chemostat and whole genome re-sequencing isolates or populations. (b) Traditional ALE applications include simple
growth selections on feedstocks containing inhibitory substrates or components, alternative substrates than those typically utilized by the strain,
exogenously added toxic products, or general stress conditions present in industrial fermentation. More pioneering ALE technologies as applied to
microbial production of bulk chemicals and fuels include engineered strains that either directly (e.g., requiring the product for biomass production)
or indirectly (e.g., by providing non-optimized pathways to balance redox potential) growth-coupled product formation (left), or that utilize product-
responsive biosensors (right) that are either employed to produce components of biomass or to negatively select against non-producers, or to
produce fluorescent reporter proteins that enable iterative rounds of cell sorting.
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reaching economically relevant product titers. Recent
examples employing ALE include detailed functional
investigation of an evolved ethanol-tolerant E. coli [55],
generation of an octanoic acid tolerant mutant with
reduced cell lysis and improved free fatty acid production
[56], and isolation of 3-hydroxypropionate tolerant
S. cerevisiae mutants with causal mutations related to
detoxification of a toxic aldehyde byproduct [27].
The use of carbon feedstocks such as CO2, or sugars
found in lignocellulosic hydrolysates (containing signifi-
cant proportions of C5 sugars such as xylose and arabi-
nose), is preferred in biofuel and bulk chemical applica-
tions due to tight economic constraints and reducing
net CO2 emissions. While many organisms exist that
by nature can utilize these substrates, it is often desired
to apply well-studied, easy-to-engineer model organisms
such as E. coli and S. cerevisiae. The development of
pentose-fermenting S. cerevisiae strains has been an
intense area of study for the past two decades [57].
ALE has also been employed to improve two remaining
troublesome aspects: C6 and C5 sugar co-utilization [58],
and C5 transport [59], in strains expressing heterologous
xylose utilization pathways. CO2 fixation by E. coli into
biomass has been achieved by heterologously expressing
RuBisCo and phosphoribulokinase, eliminating carbon
flow from glycolysis into the TCA cycle, and performing
ALE to improve growth of the resulting strain supplied
with exogenous pyruvate while reducing xylose feeding,
which was originally required [60]. Another example is
the evolution of E. coli and S. cerevisiae strains harboring
heterologous pathways for synthetic nitrogen and phos-
phorus sources, with ALE performed to further improve
utilization [61]. The use of synthetic nutrient sources
could offer economic advantages due to reduced reactor
sterilization costs or reduced antibiotic supplementation.
Enabling product formation to be a selectable phenotype
through either growth-coupled designs (see above), or the
use of biosensors within synthetic gene circuits or coupled
with flow-assisted cell sorting (FACS), is a clear direction
of much future work (Figure 3b). One pioneering work
was enhancing L-valine production in C. glutamicum using
cells expressing an L-valine responsive biosensor driving a
fluorescent reporter, where cells were sorted over subse-
quent rounds of growth [62]. While ALE has not yet been
employed, directed evolution has been performed at the
pathway and protein level coupled with the use of syn-
thetic suicide riboswitches [63] or toggled selection
schemes where both negative and positive selection
can be iteratively applied to a sensor selector to isolate
cells with improved production [64].
Conclusions
Technologies that have been introduced in the field of
systems biology (omics characterization, GEMs, ALE)
have been used extensively in engineering microbial cell
factories for production of chemicals and fuels. Recent
years have seen an increase in studies that use a broader
range of these technologies at once in order to study wild-
type platform or engineered strains. Much remains still to
be done in order to allow rapid iterative development
of cell factories based on systems strategies. The cost of
omics data collection and analysis needs to be further
reduced. GEMs need to be expanded and modeling
methods need to be developed to use quantitative omics
data and make more accurate predictions of genetic
manipulation targets. In general improved phenotypic
predictions from genotypes, especially for large numbers
of simultaneous genetic perturbations, will require
development of methods that integrate mechanistic
modeling with machine learning. Novel selection strate-
gies need to be devised to allow routine use of ALE for
optimizing metabolite production. All of these develop-
ments together with improved genome editing and other
synthetic biology methods have the potential to signifi-
cantly increase the speed at which new cell factories are
developed.
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